ACCULA FLU/SARS-COV-2 INTEGRATED TEST DEVELOPMENT | Pandemic PACT Tracker

Key facts

Disease
COVID-19, Unspecified
Start & end year
2020
2021
Known Financial Commitments (USD)
$12,991,595.11
Funder
Biomedical Advanced Research and Development Authority (BARDA)
Research Location
United States of America
Lead Research Institution
MESA BIOTECH INC
Research Priority Alignment
N/A

Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable

Abstract

ACCULA FLU/SARS-COV-2 INTEGRATED TEST DEVELOPMENT